(Q44858854)

English

Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms

scientific article published in March 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

based on heuristic

inferred from title

Carmine Pariante

object named as

Carmine M Pariante

9

0 references

author name string

Clementine Maddock

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Antonella Baita

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

M Germana Orrù

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Rossella Sitzia

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Alessandra Costa

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Elisabetta Muntoni

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

M Giulia Farci

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Bernardo Carpiniello

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

41-46

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Epidemiology of hepatitis C

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms.

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Acute effects of low-dose interferon-alpha on serum cortisol and plasma interleukin-6.

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

The glucocorticoid insensitivity syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Neurobiology of addiction and implications for treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Negative Immunoregulatory Effects of Antidepressants Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Interferons, serotonin and neurotoxicity

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Paroxetine for the prevention of depression induced by high-dose interferon alfa

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Interferon alfa-induced adverse effects in patients with a psychiatric diagnosis.

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Psychiatric complications of long-term interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Hepatitis C, interferon alfa, and depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881104040230

21 January 2018

Identifiers

10.1177/0269881104040230

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44858854&oldid=2054178407"